Combination of Methotrexate and Leflunomide Is Safe and Has Good Drug Retention Among Patients With Psoriatic Arthritis

被引:6
作者
Haroon, Muhammad [1 ,2 ]
Batool, Shabnam [1 ,2 ]
Asif, Sadia [1 ,2 ]
Hashmi, Farzana [1 ,2 ]
Ullah, Saadat [1 ,2 ]
机构
[1] Fatima Mem Hosp, Dept Rheumatol, Lahore, Pakistan
[2] FMH Coll Med & Dent, Lahore, Pakistan
关键词
D O I
10.3899/jrheum.201408
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1624 / 1625
页数:2
相关论文
共 50 条
[41]   Psoriasis outcomes in a randomized trial of etanercept and methotrexate as monotherapy or in combination in patients with psoriatic arthritis [J].
Merola, Joseph F. ;
Gottlieb, Alice B. ;
Mease, Philip ;
Strand, Vibeke ;
Kavanaugh, Arthur ;
Helliwell, Philip ;
Liu, Lyrica ;
Chung, James B. ;
Kricorian, Gregory .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) :AB118-AB118
[42]   Risk of psoriatic arthritis among patients receiving apremilast versus methotrexate for psoriasis [J].
Zhao, Sizheng Steven ;
Hernandez, Gema ;
Alam, Uazman .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2025, 92 (06) :1446-1448
[43]   Alefacept (Amevive®) in combination with methotrexate for the treatment of psoriatic arthritis. [J].
Mease, P ;
Gladman, D ;
Keystone, E .
ARTHRITIS AND RHEUMATISM, 2005, 52 (09) :S280-S280
[44]   Drug therapy and liability law in the case of the combination therapy with leflunomide and methotrexate [J].
Burgardt, C .
ZEITSCHRIFT FUR RHEUMATOLOGIE, 2002, 61 (02) :189-190
[45]   Reduced hepatotoxicity by total glucosides of paeony in combination treatment with leflunomide and methotrexate for patients with active rheumatoid arthritis [J].
Chen, Zhu ;
Li, Xiang-Pei ;
Li, Zhi-Jun ;
Xu, Liang ;
Li, Xiao-Mei .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2013, 15 (03) :474-477
[46]   Myelosuppressive and hepatotoxic potential of leflunomide and methotrexate combination in a rat model of rheumatoid arthritis [J].
Shymaa E. Bilasy ;
Soha S. Essawy ;
Mohamed F. Mandour ;
Eman A. I. Ali ;
Sawsan A. Zaitone .
Pharmacological Reports, 2015, 67 :102-114
[47]   Myelosuppressive and hepatotoxic potential of leflunomide and methotrexate combination in a rat model of rheumatoid arthritis [J].
Bilasy, Shymaa E. ;
Essawy, Soha S. ;
Mandour, Mohamed F. ;
Ali, Eman A. I. ;
Zaitone, Sawsan A. .
PHARMACOLOGICAL REPORTS, 2015, 67 (01) :102-114
[48]   Psoriatic arthritis improved on risankizumab: does the presence of psoriatic arthritis mean a drug approved for psoriatic arthritis has to be prescribed? [J].
Singh, Rohan ;
Brown, Alexandria M. ;
Chan, Warren H. ;
Farr, Morgan A. ;
Venkataraman, Sid ;
Feldman, Steven R. .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2022, 22 (12) :1439-1441
[49]   INCIDENCE OF HEPATOTOXICITY IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH METHOTREXATE AND LEFLUNOMIDE [J].
Agostina Gatica, Maria ;
Cichillitti, Lucia ;
Ringer, Ariana ;
Pablo Ruffino, Juan ;
Carbone, Dianela ;
Abdala, Brian ;
Lucci, Franco ;
Gallo, Carolina ;
Nicola, Marianela ;
Abdala, Marcelo .
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2023, 29 :S79-S79
[50]   THE EFFECTS OF MTHFR GENE VARIATIONS ON DRUG RESPONSE IN RHEUMATOID ARTHRITIS AND PSORIATIC ARTHRITIS PATIENTS TREATED WITH METHOTREXATE [J].
Horelli-Kuitunen, N. ;
Kaistamaa, M. ;
Onkamo, P. ;
Nenonen, A. ;
Ahola, L. ;
Ihalainen, J. ;
Laiho, K. ;
Kauppi, M. ;
Nystrom, M. .
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2009, 38 (05) :405-405